Manuel Bayona
Biographic Data
| ID | 6683534 |
|---|---|
| NAME | Manuel Bayona |
| GIVEN NAMES | Manuel |
| FAMILY NAME | Bayona |
| SIGNATURE | BAYONA M |
| AFFILIATIONS | University of South Florida |
| ORCID | 0009-0001-6543-1229 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1996 |
| LATEST PUBLICATION YEAR | 1998 |
| H-INDEX | 0 |
The Onchocerciasis Elimination Program for the Americas
The decision in 1987 by the pharmaceutical firm Merck & Co. to provide Mectizan (ivermectin) free of charge to river blindness control programs has challenged the international public health community to find effective ways to distribute the drug to rural populations most affected by onchocerciasis. In the Americas, PAHO responded to that challenge by calling for the elimination of all morbidity from onchocerciasis from the Region by the year 200…
Gender and Ethnic Differences in Survival in a Cohort of HIV Positive Clients
European Americans entered treatment at a much earlier disease stage (as measured by CD4 positive T-lymphocyte counts) and had higher educational levels (a surrogate for socioeconomic status) than African Americans. These factors may explain the longer survival in European Americans as compared to African Americans in this cohort
No prominent works on this page.
Gender and Ethnic Differences in Survival in a Cohort of HIV Positive Clients
European Americans entered treatment at a much earlier disease stage (as measured by CD4 positive T-lymphocyte counts) and had higher educational levels (a surrogate for socioeconomic status) than African Americans. These factors may explain the longer survival in European Americans as compared to African Americans in this cohort
The Onchocerciasis Elimination Program for the Americas
The decision in 1987 by the pharmaceutical firm Merck & Co. to provide Mectizan (ivermectin) free of charge to river blindness control programs has challenged the international public health community to find effective ways to distribute the drug to rural populations most affected by onchocerciasis. In the Americas, PAHO responded to that challenge by calling for the elimination of all morbidity from onchocerciasis from the Region by the year 200…
Medicine (2 works) · Business (1 work) · Cohort (1 work) · Cohort study (1 work) · Critical mass (sociodynamics (1 work) · Demography (1 work) · Demography (1 work) · Donation (1 work) · Economic growth (1 work) · Economics (1 work)